149 related articles for article (PubMed ID: 23409951)
21. Human fetal ventricular cardiomyocyte, RL-14 cell line, is a promising model to study drug metabolizing enzymes and their associated arachidonic acid metabolites.
Maayah ZH; Elshenawy OH; Althurwi HN; Abdelhamid G; El-Kadi AO
J Pharmacol Toxicol Methods; 2015; 71():33-41. PubMed ID: 25454080
[TBL] [Abstract][Full Text] [Related]
22. Effects of dioxane on cytochrome P450 enzymes in liver, kidney, lung and nasal mucosa of rat.
Nannelli A; De Rubertis A; Longo V; Gervasi PG
Arch Toxicol; 2005 Feb; 79(2):74-82. PubMed ID: 15490126
[TBL] [Abstract][Full Text] [Related]
23. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome P450 pathways of arachidonic acid metabolism.
Kroetz DL; Zeldin DC
Curr Opin Lipidol; 2002 Jun; 13(3):273-83. PubMed ID: 12045397
[TBL] [Abstract][Full Text] [Related]
25. 3-methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats.
Aboutabl ME; Zordoky BN; El-Kadi AO
Br J Pharmacol; 2009 Dec; 158(7):1808-19. PubMed ID: 19889059
[TBL] [Abstract][Full Text] [Related]
26. The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.
Schuck RN; Zha W; Edin ML; Gruzdev A; Vendrov KC; Miller TM; Xu Z; Lih FB; DeGraff LM; Tomer KB; Jones HM; Makowski L; Huang L; Poloyac SM; Zeldin DC; Lee CR
PLoS One; 2014; 9(10):e110162. PubMed ID: 25310404
[TBL] [Abstract][Full Text] [Related]
27. Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism.
Theken KN; Deng Y; Schuck RN; Oni-Orisan A; Miller TM; Kannon MA; Poloyac SM; Lee CR
Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E500-9. PubMed ID: 22185841
[TBL] [Abstract][Full Text] [Related]
28. Vascular cytochrome p450 enzymes: physiology and pathophysiology.
Fleming I
Trends Cardiovasc Med; 2008 Jan; 18(1):20-5. PubMed ID: 18206805
[TBL] [Abstract][Full Text] [Related]
29. Determination of the dominant arachidonic acid cytochrome p450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics.
El-Sherbeni AA; Aboutabl ME; Zordoky BN; Anwar-Mohamed A; El-Kadi AO
AAPS J; 2013 Jan; 15(1):112-22. PubMed ID: 23139020
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11.
Powell PK; Wolf I; Jin R; Lasker JM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1327-36. PubMed ID: 9618440
[TBL] [Abstract][Full Text] [Related]
31. Effect of aging on renal cytochrome P450-dependent arachidonic acid metabolism in Dahl rats.
Omata K; Tsutsumi E; Sheu HL; Utsumi Y; Abe K
J Lipid Mediat; 1993; 6(1-3):369-73. PubMed ID: 8357995
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform.
Zeldin DC; DuBois RN; Falck JR; Capdevila JH
Arch Biochem Biophys; 1995 Sep; 322(1):76-86. PubMed ID: 7574697
[TBL] [Abstract][Full Text] [Related]
33. Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.
Alsaad AM; Zordoky BN; Tse MM; El-Kadi AO
Drug Metab Rev; 2013 May; 45(2):173-95. PubMed ID: 23600686
[TBL] [Abstract][Full Text] [Related]
34. Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy.
El-Sherbeni AA; El-Kadi AO
Biochem Pharmacol; 2014 Feb; 87(3):456-66. PubMed ID: 24300133
[TBL] [Abstract][Full Text] [Related]
35. Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism.
Theken KN; Deng Y; Kannon MA; Miller TM; Poloyac SM; Lee CR
Drug Metab Dispos; 2011 Jan; 39(1):22-9. PubMed ID: 20947618
[TBL] [Abstract][Full Text] [Related]
36. Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway.
Zeldin DC; Moomaw CR; Jesse N; Tomer KB; Beetham J; Hammock BD; Wu S
Arch Biochem Biophys; 1996 Jun; 330(1):87-96. PubMed ID: 8651708
[TBL] [Abstract][Full Text] [Related]
37. Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy.
Althurwi HN; Elshenawy OH; El-Kadi AO
J Cardiovasc Pharmacol; 2014 Feb; 63(2):167-77. PubMed ID: 24157956
[TBL] [Abstract][Full Text] [Related]
38. Inducibility of AhR-regulated CYP genes by beta-naphthoflavone in the liver, lung, kidney and heart of the pig.
Chirulli V; Marvasi L; Zaghini A; Fiorio R; Longo V; Gervasi PG
Toxicology; 2007 Oct; 240(1-2):25-37. PubMed ID: 17804143
[TBL] [Abstract][Full Text] [Related]
39. Dynamic expression of epoxyeicosatrienoic acid synthesizing and metabolizing enzymes in the primate corpus luteum.
Irusta G; Murphy MJ; Perez WD; Hennebold JD
Mol Hum Reprod; 2007 Aug; 13(8):541-8. PubMed ID: 17567599
[TBL] [Abstract][Full Text] [Related]
40. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.
Spector AA; Fang X; Snyder GD; Weintraub NL
Prog Lipid Res; 2004 Jan; 43(1):55-90. PubMed ID: 14636671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
